Marksans Pharma has informed that the Meeting of the Board of Directors of the Company will be held on Monday, 6th August, 2018 at Mumbai, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended 30th June, 2018. As per the Insider Trading Code of the Company, the Trading Window for dealing in Company’s shares will remain closed for the Company’s insiders from today i.e. 27th July, 2018 (Commencing from the time of above intimation to the Stock Exchanges) till Forty-Eight hours after the announcement of the Unaudited Financial Results on 6th August, 2018.
The above information is a part of company’s filings submitted to BSE.
